MedTrace Logo

Correlation of HbA1c With Electrophysiological Studies and Gait Performance in Diabetic Polyneuropathy Patients

NCT05457192 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2022-07-13

No results posted yet for this study

Summary

This study will be conducted to investigate the relationship between glycosylated hemoglobin (HbA1c) and nerve conduction studies (NCS) with gait performance in patients with DPN. 65 patients with type II DM with moderate polyneuropathy will participate in this study. Glycosylated Hemoglobin (HbA1c) test will be done for each patient by using the Colorimeter device. Nerve conduction studies (NCS) will be performed for each patient by using the electromyography device to confirm the diagnosis of DPN. The neurophysiological functions of peripheral nerves including (The Common peroneal, Tibial, Sural, and Ulnar motor \& sensory branches) will be measured. Spatiotemporal gait parameters (stride length, cadence\& velocity) for all the patients will be assessed by two-dimension video-based motion analysis (2D).

Conditions

  • Diabetic Polyneuropathy

Sponsors & Collaborators

  • Shereen Saad Eldin Mohamed Ali

    lead OTHER

Principal Investigators

  • Shereen Saad Eldin Mohamed, Lecturer · lecturer of Neurology at faculty of physical therapy-Cairo university

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2022-10-31
Completion
2022-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05457192 on ClinicalTrials.gov